| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/16/2000 | US6063603 Kit for simple and efficient isothermal accumulation of preferential nucleotide sequences |
| 05/16/2000 | US6063601 Chimaeric gene coding for a transit peptide and a heterologous peptide |
| 05/16/2000 | US6063600 DNA encoding canine interleukin-1 receptor antagonist |
| 05/16/2000 | US6063599 Nucleic acid sequence of parasite polypeptide; for diagnosis of parasitic helminth infection; for the development of vaccines to prevent helminth and nematode infection |
| 05/16/2000 | US6063598 Strong homologous promoter obtained from hamsters |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063595 Method of forming a macromolecular microgene polymer |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063582 Methods of screening for compounds that interact with human P2u2 purinergic receptor |
| 05/16/2000 | US6063578 Dual reporter system and methods of use therefor |
| 05/16/2000 | US6063574 Dioxetane labeled probes and detection assays employing the same |
| 05/16/2000 | US6063572 Method of assay of nucleic acid sequences |
| 05/16/2000 | US6063571 Process for amplifying nucleic acids using DNA/PNA primers |
| 05/16/2000 | US6063570 Nucleotide sequence coding a plant enzyme; for the detoxification of plants and seeds |
| 05/16/2000 | US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof |
| 05/16/2000 | US6063566 Enzymatic ribonucleic acid molecule which catalyzes the position preferential cleavage of single-stranded deoxyribonucleic |
| 05/16/2000 | US6063565 Double receptor polynucleotide assay method |
| 05/16/2000 | US6063563 Method of PCR testing of pooled blood samples |
| 05/16/2000 | US6063562 In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst |
| 05/16/2000 | US6063561 Erythromycin derivatives in which methyl groups on the macrolactone ring are substituted with hydrogen, ethyl and/or hydroxy groups and the ethyl side-chain has been substituted with hydroxymethyl or dihydroxycyclohexylmethyl side-chains |
| 05/16/2000 | US6063377 Rho protein |
| 05/16/2000 | US6063375 Semiallogeneic cell hybrids and related methods for treating cancer |
| 05/16/2000 | US6063374 Administering hybrid gene |
| 05/16/2000 | CA2271826A1 Methods and compositions for increasing the infectively of retroviruses |
| 05/16/2000 | CA2131826C Mn gene and protein |
| 05/16/2000 | CA1340992C Process for the production of recombinant porcine growth hormone polypeptides |
| 05/11/2000 | WO2000026819A1 Methods and apparatus for performing pattern dictionary formation for use in sequence homology detection |
| 05/11/2000 | WO2000026818A1 Methods and apparatus for performing sequence homology detection |
| 05/11/2000 | WO2000026667A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/11/2000 | WO2000026666A2 Multiple marker characterization of single cells |
| 05/11/2000 | WO2000026418A1 Human pan-hcv human monoclonal antibodies |
| 05/11/2000 | WO2000026417A1 Detection of negative-strand rna viruses |
| 05/11/2000 | WO2000026415A2 A method for genomic substractive hybridization |
| 05/11/2000 | WO2000026413A1 Determining signal transduction pathways |
| 05/11/2000 | WO2000026411A1 Method for making complementary oligonucleotide tag sets |
| 05/11/2000 | WO2000026408A2 A system for cell-based screening |
| 05/11/2000 | WO2000026407A1 Method for determining cancer by determining expression of mage-10 |
| 05/11/2000 | WO2000026406A1 METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAs |
| 05/11/2000 | WO2000026404A1 Method for detecting gene affected by endocrine disruptor |
| 05/11/2000 | WO2000026402A1 Method and test kit for analyzing dns repair |
| 05/11/2000 | WO2000026401A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA) |
| 05/11/2000 | WO2000026397A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 05/11/2000 | WO2000026396A1 A method of recombination and agents useful for same |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026394A1 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 05/11/2000 | WO2000026392A2 MUTANT MOUSE CONTAINING A KNOCKOUT MUTATION IN DNA ENCODING AN ENDOGENOUS α4 SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR |
| 05/11/2000 | WO2000026391A2 Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
| 05/11/2000 | WO2000026390A2 Genes and vectors for conferring herbicide resistance in plants |
| 05/11/2000 | WO2000026389A2 Dna comprising rice anther-specific gene and transgenic plant transformed therewith |
| 05/11/2000 | WO2000026388A2 Novel expression cassette for expressing genes in plant seed |
| 05/11/2000 | WO2000026387A1 Vector for the transformation of phaffia rhodozyma and process of transformation thereby |
| 05/11/2000 | WO2000026386A1 Transformation vector system |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026384A1 Lps with reduced toxicity from genetically modified gram negative bacteria |
| 05/11/2000 | WO2000026383A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | WO2000026382A1 Thioredoxin reductase ii |
| 05/11/2000 | WO2000026381A2 High fidelity thermostable ligase and uses thereof |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026378A1 POLYPEPTIDE COMPOSITIONS TOXIC TO DIABROTICA INSECTS, OBTAINED FROM BACILLUS THURINGIENSIS; CryET70, AND METHODS OF USE |
| 05/11/2000 | WO2000026377A1 POLYNUCLEOTIDES AND POLYPEPTIDES ENCODING metK ISOLATED FROM $i(STREPTOCCOCCUS PNEUMONIAE) |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026375A2 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 05/11/2000 | WO2000026374A2 Adipose specific protein |
| 05/11/2000 | WO2000026373A1 MURINE EXPRESSION OF HUMAN Igμ LOCUS |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026371A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026369A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 05/11/2000 | WO2000026368A2 Therapeutic antiangiogenic endostatin compositions |
| 05/11/2000 | WO2000026367A2 Therapeutics and diagnostics for ocular abnormalities |
| 05/11/2000 | WO2000026366A1 Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins |
| 05/11/2000 | WO2000026365A1 NOVEL GENE AND PROTEIN ERRη ENCODED THEREBY |
| 05/11/2000 | WO2000026364A1 Regulator of notch signaling activity |
| 05/11/2000 | WO2000026363A1 GENOMIC AND COMPLETE cDNA SEQUENCES OF HUMAN ADIPOCYTE-SPECIFIC APM1 AND BIALLELIC MARKERS THEREOF |
| 05/11/2000 | WO2000026362A2 Proteins of the stomatin family and their use as target proteins for pain therapy |
| 05/11/2000 | WO2000026361A1 New protein associated with leptin receptor for obesity and the encoding sequence thereof and the methods for producing same and the uses of the same |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026357A2 Transgenic and cloned mammals |
| 05/11/2000 | WO2000026356A1 Glufosinate tolerant rice |
| 05/11/2000 | WO2000026355A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 05/11/2000 | WO2000026354A1 Glycosylated proteins having reduced allergenicity |
| 05/11/2000 | WO2000026352A1 Novel trypsin family serine proteases |
| 05/11/2000 | WO2000026349A2 Recombinant oleandolide polyketide synthase |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026346A1 Plants having enhanced gall resistance and methods and compositions for producing same |
| 05/11/2000 | WO2000026345A1 Glufosinate tolerant rice |
| 05/11/2000 | WO2000026344A1 Peptides with enhanced stability to protease degradation |
| 05/11/2000 | WO2000026343A2 Tissue specific promoters and transgenic animals for the screening of pharmaceuticals |
| 05/11/2000 | WO2000026340A2 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 05/11/2000 | WO2000026255A1 Anti-petasin antibodies, methods for the production thereof and their use |
| 05/11/2000 | WO2000026254A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 05/11/2000 | WO2000026253A1 Human potassium channel (h-traak) |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026248A2 Tuberculosis diagnostic test |
| 05/11/2000 | WO2000026247A2 Ikaros isoforms and mutants |
| 05/11/2000 | WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |